Overview

Trial to Evaluate the Efficacy of Fluvastatin on Certain Markers

Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
To analyze efficacy of fluvastatin on patients with chronic renal disease by analyzing certain inflammatory markers. In addition, tolerability and safety will also be evaluated in a Spanish population.
Phase:
Phase 4
Details
Lead Sponsor:
Novartis
Treatments:
Fluvastatin